Share

Search your stocks

Ctrl+K

Vanta Bioscience Ltd.Vanta Bioscience Ltd.

22.65(-9.98%)

1W: +3.84%

1M: -15.91%

1Y: -60.38%

Vanta Bioscience Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth observed over the past four quarters, indicating strong demand for products.
Improvement in profit margins suggests effective cost management strategies in place.
Increase in R&D expenditure signals commitment to innovation and future growth potential.

NEGATIVES

Deterioration in net profit margins compared to previous quarters raises concerns about efficiency.
Higher operating costs noted, potentially impacting overall profitability moving forward.
Fluctuations in cash flow highlight potential liquidity issues that may affect operations.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-